Meditrina, Inc. makes the Aveta System, a single-use device for intrauterine tissue removal in hysteroscopic procedures.
Founded in 2016 in Cupertino, US, by John Shadduck, Meditrina, Inc. sells the Aveta System to gynecological clinics and hospital operating rooms for procedures such as fibroid removal, polypectomy and diagnostic hysteroscopy. Revenue comes from bulk and procurement sales to healthcare facilities. In June 2020, the company raised USD 10.00 mn in venture funding, part of a USD 20.00 mn equity round led by Deerfield Management. The company is valued at USD 70.31 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in